Form 4: Fulgent Genetics CFO Paul Kim Reports Tax Withholding Stock Transaction
SEC Form 4 Filing
CFO of Fulgent Genetics, Paul Kim, reports disposition of shares to cover tax obligations from vesting restricted stock units.
Summary
- On April 26, 2025, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving common stock.
- A total of 2,743 shares were disposed of at a price of $18.88 per share to satisfy tax withholding obligations.
- Following the transaction, Kim directly owns 345,539 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a routine transaction related to tax obligations.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of the Agreement and Plan of Merger by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. |
| November 9, 2022 | Date of Form 4 filing with the U.S. Securities and Exchange Commission reporting the awards originally. |
| April 26, 2025 | Date of the stock transaction (disposal of shares for tax withholding). |
| April 29, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Fulgent Genetics, FLGT, Paul Kim, CFO, Stock Transaction, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.